The role of medical affairs (MA) and disease-state education has become essential in advancing patient care and supporting ...

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

The European Academy of Allergy and Clinical Immunology (EAACI) has launched the first World Anaphylaxis Awareness Day today ...

PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Communicating complex medical information has the potential to overwhelm patients and caregivers. The key is blending ...

Pfizer has appointed Chris Boshoff, its current chief oncology officer and executive vice president, as chief scientific ...

In many pharma companies, progression of a product (or asset) through development is gated by a series of governance ...

Traditionally, stories include several key elements: characters, setting, plot and an inciting incident to catalyse the rest of the story through climax and resolution. Stories also have causality – ...

UCB’s Bimzelx (bimekizumab-bkzx) has been approved by the US Food and Drug Administration (FDA) to treat active moderate-to-severe hidradenitis suppurativa (HS) in adults. Estimated to affect one in ...